KSE - Delayed Quote KRW

SK Biopharmaceuticals Co., Ltd. (326030.KS)

92,100.00
+100.00
+(0.11%)
At close: 3:30:23 PM GMT+9
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
94,899,993
94,899,993
-94,201,249.07
-159,920,061.63
-92,871,732.61
Investing Cash Flow
-10,940,812.68
-10,940,812.68
225,272,590.65
-95,713,805.55
258,971,494.29
Financing Cash Flow
-4,498,072.08
-4,498,072.08
6,622,755.58
134,914,262.30
-4,645,851
End Cash Position
322,806,911.40
322,806,911.40
239,700,042.44
104,059,702.56
225,922,278.25
Capital Expenditure
-13,424,369.32
-13,424,369.32
-3,249,365.01
-5,960,948.06
-5,991,899.63
Issuance of Debt
100,000,000
100,000,000
--
141,751,150
--
Repayment of Debt
-100,000,000
-100,000,000
--
--
--
Free Cash Flow
81,475,623.68
81,475,623.68
-97,450,614.08
-165,881,009.69
-98,863,632.24
12/31/2021 - 7/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers